口服补液盐（ORS）全球市场规模、份额、趋势和成长分析报告（2026-2034）

预计口服补液盐 (ORS) 市场规模将从 2025 年的 36.1 亿美元成长到 2034 年的 84.8 亿美元，2026 年至 2034 年的复合年增长率为 9.97%。

随着对有效补液疗法的需求不断增长，口服补液盐（ORS）市场预计将迎来显着增长，尤其是在腹泻和其他胃肠道疾病导致脱水高发的地区。 ORS 是一种便捷且经济有效的补充体液和电解质的方案，使其成为公共卫生措施的重要组成部分。人们对补液重要性的认识不断提高，以及 ORS 在预防严重脱水方面的有效性日益凸显，正在推动全球对 ORS 的需求。

技术创新在塑造口服补液盐（ORS）市场的未来方面发挥关键作用。配方科学的创新，包括风味型和即饮型ORS产品的开发，正在提高患者的接受度和使用便利性，尤其是在儿童群体中。此外，包装技术和分销方式的进步也改善了服务不足地区取得ORS的途径。随着製造商持续加大研发投入，我们预期ORS将在包括医院、诊所和社区健康计画在内的各种医疗机构中得到更广泛的应用。

此外，人们对预防性医疗保健和教育日益增长的兴趣正在推动口服补液盐（ORS）市场的成长。随着医疗保健机构和组织致力于提高人们对脱水的认识并推广ORS的益处，对教育资源和社区宣传计画的需求也日益增长。这一趋势促使製造商、医疗专业人员和公共卫生组织加强合作，共同推动帮助个人和家庭有效管理水分的各项工作。随着市场的不断发展，技术、教育和社区参与的整合将是成功的关键。

目录

第一章 引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 绘製渗透率和成长前景图
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 市场问题
• 波特五力分析
• PESTLE分析

4. 全球口服补液盐 (ORS) 市场依产品类型划分

• 市场分析、洞察与预测
• 药片
• 粉末
• 解决方案

5. 全球口服补液盐 (ORS) 市场按应用领域划分

• 市场分析、洞察与预测
• 医院
• 诊所
• 居家照护
• 其他的

6. 全球口服补液盐 (ORS) 市场依分销管道划分

• 市场分析、洞察与预测
• 网路商店
• 药局
• 超级市场和大卖场
• 专卖店
• 其他的

7. 全球口服补液盐（ORS）市场（依最终用户划分）

• 市场分析、洞察与预测
• 婴儿
• 孩子们
• 成人
• 老年人

8. 全球口服补液盐（ORS）市场（依地区划分）

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商格局（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Johnson & Johnson
  • Sanofi
  • Pfizer Inc
  • Abbott Laboratories
  • GlaxoSmithKline Plc
  • Bayer AG
  • Novartis AG
  • Merck & Co.Inc
  • F. Hoffmann-La Roche Ltd
  • Cipla Limited
  • Sun Pharmaceutical Industries Ltd
  • Daiichi Sankyo Company, Limited
  • Reckitt Benckiser Group Plc
  • NestlAfA（C）SA
  • Baxter International Inc

The Oral Rehydration Solution (ORS) Market size is expected to reach USD 8.48 Billion in 2034 from USD 3.61 Billion (2025) growing at a CAGR of 9.97% during 2026-2034.

The Oral Rehydration Solution (ORS) Market is poised for significant growth as the demand for effective rehydration therapies increases, particularly in regions with high incidences of dehydration due to diarrhea and other gastrointestinal disorders. ORS is a simple and cost-effective solution that helps replenish lost fluids and electrolytes, making it a critical component of public health initiatives. The rising awareness of the importance of hydration and the effectiveness of ORS in preventing severe dehydration is driving the demand for these solutions globally.

Technological advancements are playing a crucial role in shaping the future of the ORS market. Innovations in formulation science, including the development of flavored and ready-to-use ORS products, are enhancing the acceptability and ease of use for patients, particularly children. Additionally, advancements in packaging and distribution methods are improving access to ORS in underserved areas. As manufacturers continue to invest in research and development, the ORS market is likely to see increased adoption across various healthcare settings, including hospitals, clinics, and community health programs.

Moreover, the growing emphasis on preventive healthcare and education is influencing the ORS market's growth trajectory. As healthcare providers and organizations focus on promoting awareness of dehydration and the benefits of ORS, there is a rising demand for educational resources and community outreach programs. This trend is driving collaboration between manufacturers, healthcare professionals, and public health agencies to develop initiatives that empower individuals and families to manage hydration effectively. As the market continues to evolve, the integration of technology, education, and community engagement will be key drivers of success.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Tablets
• Powders
• Solutions

By Application

• Hospitals
• Clinics
• Home Care
• Others

By Distribution Channel

• Online Stores
• Pharmacies
• Supermarkets/Hypermarkets
• Specialty Stores
• Others

By End-User

• Infants
• Children
• Adults
• Elderly

COMPANIES PROFILED

• Johnson Johnson, Sanofi, Pfizer Inc, Abbott Laboratories, GlaxoSmithKline plc, Bayer AG, Novartis AG, Merck Co, Inc, F HoffmannLa Roche Ltd, Cipla Limited, Sun Pharmaceutical Industries Ltd, Daiichi Sankyo Company, Limited, Reckitt Benckiser Group plc, Nestl SA, Baxter International Inc

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Tablets Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Powders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Solutions Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Home Care Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Distribution Channel
• 6.2. Online Stores Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Supermarkets/Hypermarkets Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Specialty Stores Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET: BY END-USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-user
• 7.2. Infants Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Children Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Adults Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Elderly Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL ORAL REHYDRATION SOLUTION (ORS) MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product Type
  • 8.2.2 By Application
  • 8.2.3 By Distribution Channel
  • 8.2.4 By End-user
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product Type
  • 8.3.2 By Application
  • 8.3.3 By Distribution Channel
  • 8.3.4 By End-user
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product Type
  • 8.4.2 By Application
  • 8.4.3 By Distribution Channel
  • 8.4.4 By End-user
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product Type
  • 8.5.2 By Application
  • 8.5.3 By Distribution Channel
  • 8.5.4 By End-user
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product Type
  • 8.6.2 By Application
  • 8.6.3 By Distribution Channel
  • 8.6.4 By End-user
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL ORAL REHYDRATION SOLUTION (ORS) INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Johnson & Johnson
  • 10.2.2 Sanofi
  • 10.2.3 Pfizer Inc
  • 10.2.4 Abbott Laboratories
  • 10.2.5 GlaxoSmithKline Plc
  • 10.2.6 Bayer AG
  • 10.2.7 Novartis AG
  • 10.2.8 Merck & Co.Inc
  • 10.2.9 F. Hoffmann-La Roche Ltd
  • 10.2.10 Cipla Limited
  • 10.2.11 Sun Pharmaceutical Industries Ltd
  • 10.2.12 Daiichi Sankyo Company, Limited
  • 10.2.13 Reckitt Benckiser Group Plc
  • 10.2.14 NestlAfA(C) S.A
  • 10.2.15 Baxter International Inc